New PET tracers could illuminate immune battle inside lung tumors

This trial is testing two experimental PET imaging tracers to see if they can show T cell activity in lung cancer tumors. People with non-small cell lung cancer who are about to have surgery after standard chemo-immunotherapy will receive two PET scans. The scans will be compared to each other and to the removed tumor tissue to see if the tracers accurately reflect immune cell presence and activation. The goal is to find better ways to predict how well immunotherapy works.